-
Signature
-
/s/ Rahsaan Thompson, Attorney-in-Fact for Karin Jooss
-
Stock symbol
-
GRTS
-
Transactions as of
-
Jan 31, 2022
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
4/20/2022, 04:40 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
GRTS |
Common Stock |
Award |
$0 |
+27.6K |
+7.89% |
$0.00 |
377K |
Jan 31, 2022 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
GRTS |
Stock Option (Right to Buy) |
Award |
$0 |
+166K |
|
$0.00 |
166K |
Jan 31, 2022 |
Common Stock |
166K |
$5.46 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Executive Vice President and Head of Research and Development